VES-HI Destination | Comunitats I-CERCA

Home
Communities
Organizations
Portfolios
Events
Programmes

Categories

Your selection corresponds to 28 entries

Leuven, Belgium

Bio-Incubator LeuvenThe Bio-Incubator in Leuven provides a dynamic and stimulating environment for biotech companies, offering flexible office and lab space, technical support, and a network of professionals. It's located in the Leuven Arenberg Science Park, offering access to key research institutions and expertise. The Bio-Incubator supports both start-ups and established companies with strong R&D activities, facilitating the development of new technologies and products.

Facilities: The Bio-Incubator offers modular, state-of-the-art laboratory and office spaces, adaptable to the needs of young and growing companies.
Support: The incubator provides technical, logistical, and environmental support, along with expert advice from qualified staff and a professional network.
Location: Situated in the Arenberg Science Park, it's near KU Leuven, VIB research facilities, and imec, fostering collaboration and innovation.
Focus: The incubator primarily supports research-driven biotechnology companies with high growth potential.
Flexibility: The Bio-Incubator's facilities are designed to be flexible and adaptable, allowing companies to scale their operations as they grow.
Network: It provides a network of professionals and access to other biotech companies, facilitating collaboration and knowledge sharing.
Expansion: The Bio-Incubator is expanding with new buildings, like Bio-Incubator 4 and 5, to meet the growing demand for research and development space.

Leuven, Belgium

Centre for Drug Design and Discovery - CD3 LeuvenCD3 Leuven, or the Centre for Drug Design and Discovery, is an investment fund and drug discovery center in Leuven, Belgium, dedicated to translating innovative biomedical research into new medicines. It bridges the gap between academic research and the pharmaceutical industry, investing in projects, developing drugs, and partnering with biotechs and pharma companies.
Here's a more detailed breakdown:
Investment Fund:
CD3 invests in early-stage drug discovery projects, spin-off companies, and biotechs, providing financial support for bringing promising research to the clinic.
Drug Discovery Center:
CD3 complements its investments with a drug discovery team and infrastructure to validate research, develop potential drug candidates, and bring them closer to clinical trials.
Collaboration:
A core function of CD3 is collaborating with academic research groups and biotech companies, leveraging their expertise and innovative science.
Technology Transfer:
CD3 facilitates the transfer of innovative research from universities and academic institutions into the pharmaceutical industry, ultimately benefiting patients.
Goal:
The ultimate goal of CD3 is to discover and develop new medicines that can be used to treat various diseases, working closely with pharmaceutical companies to bring these drugs to market.

Leuven, Belgium

University Hospital LeuvenUZ Leuven is a leading university hospital in Leuven, Belgium, known for its specialized care, research, and training in various medical fields. It focuses on delivering high-quality patient care, fostering innovation, and contributing to advancements in medical research.

What UZ Leuven does:
Patient Care: UZ Leuven provides a wide range of specialized care, including advanced procedures like fetal surgery and kidney transplants, with a focus on individual patient needs.
Medical Research: UZ Leuven is a hub for medical research, with a strong emphasis on clinical research and biomedical research. They are actively involved in clinical trials and research into various conditions, including cancer, kidney disease, and neurological disorders.
Medical Training: UZ Leuven is a major training ground for future doctors and healthcare professionals, partnering with the KU Leuven university to offer a comprehensive range of medical education programs.
Innovation and Technology: UZ Leuven invests in state-of-the-art technology and innovative treatments, including proton therapy, to improve patient outcomes.
International Collaboration: UZ Leuven actively participates in international collaborations and networks to share knowledge and expertise, contributing to advancements in global healthcare.
Infrastructure and Masterplan: UZ Leuven is implementing a masterplan to modernize its infrastructure, including new facilities for intensive care, operating theaters, and other key areas, with support from the European Investment Bank.

Leuven, Belgium

KU Leuven LRDKU Leuven Research & Development (LRD) is the technology transfer office (TTO) for the KU Leuven Association, acting as a bridge between the university's research and industry. LRD's main functions include managing research collaboration agreements with industry, providing support for spin-off company creation, and managing the university's intellectual property portfolio. They also offer advice and support for researchers, including legal and administrative assistance.

LRD's activities:
Managing Research Collaboration Agreements: LRD handles all research collaboration agreements between KU Leuven and industry, ranging from small consulting projects to long-term research collaborations.
Spin-off Company Support: LRD actively supports the creation of spin-off companies by providing advice, support, access to seed capital, and infrastructure, as well as assisting with legal, business, and financial matters.
Intellectual Property Management: LRD manages the university's patent portfolio, offering licensing opportunities to companies and providing support to researchers on intellectual property rights.
Promoting Entrepreneurship and Innovation: LRD encourages entrepreneurship and innovation by fostering networking initiatives and technology clustering within the region.
Knowledge and Technology Transfer: LRD facilitates the transfer of knowledge and technology between KU Leuven and industry, helping researchers translate their research into impactful innovations.
Support for Researchers: LRD offers a range of support services to researchers, including guidance on navigating the research collaboration process, advice on intellectual property protection, and assistance with patent applications.

CEMMCeMM (Research Center for Molecular Medicine of the Austrian Academy of Sciences) in Vienna focuses on advancing the understanding of human diseases through basic and biomedical research, with a particular emphasis on developing precise, personalized, predictive, and preventive medicine. Their work centers around post-genomic technologies and investigates areas like cancer, immune disorders, infections, metabolic disorders, and aging.

Research Focus: CeMM conducts research on a range of medically relevant topics, including cancer, inflammation/immune disorders, rare diseases, and aging. They also have a strategic interest in blood and personalized medicine.
Interdisciplinary Approach: CeMM promotes interdisciplinary research by bringing together scientists from various backgrounds, such as computer science, medicine, life sciences, mathematics, chemistry, and physics, to solve complex scientific problems.
Translational Research: CeMM strives to bridge the gap between basic research and clinical applications, aiming to translate scientific discoveries into innovative therapeutic and diagnostic strategies.
Cutting-Edge Technologies: CeMM provides access to advanced technological platforms, including deep sequencing, proteomics, chemical biology, and bioinformatics, to facilitate their research efforts.
Collaboration and Training: CeMM fosters strong collaborations with the Medical University of Vienna and the Vienna General Hospital, and also trains a new generation of researchers through their PhD program.
Location and Infrastructure: CeMM is located on the Medical Campus Vienna, one of the largest in Europe, providing access to the Medical University of Vienna, the Vienna General Hospital, and the Children's Cancer Research Institute (CCRI).

EU-LIFE Utopia Conference 2024The EU-LIFE Utopia Conference 2024, held in Vienna on April 26, 2024, explored the potential of artificial intelligence (AI) in biology and biomedicine, focusing on a social innovation experiment. It brought together the scientific, administrative, and management communities of EU-LIFE to discuss the implications of AI in their field and envision its future. The conference included presentations on AI-driven projects and a range of perspectives on AI applications, including legal and ethical considerations.

Focus on AI: The conference's central theme was the application of AI in life sciences research, particularly in biology and biomedicine.
Social Innovation Experiment: It was framed as a social innovation experiment, meaning it aimed to explore how AI could be used to create positive societal impact within the research community.
Diverse Perspectives: The conference featured presentations from various perspectives on AI, including those from research projects, legal experts, and stakeholders in the European AI Act.
Community Engagement: It was part of a larger EU-LIFE Community Meeting in Vienna, which involved working groups and other activities.
Future Vision: The conference aimed to stimulate discussion about the future of AI in research, envisioning its potential impact on the field and beyond.
Report Published: A report summarizing the conference's key discussions and conclusions was published

EU-LIFE Community Meeting 2024The EU-LIFE Community Meeting is an annual gathering for all members of the EU-LIFE alliance, a group of leading European research institutes in the life sciences. It serves as a platform for exchanging ideas, aligning strategies, and planning for the future of research in Europe. The meeting also provides an opportunity for working groups to meet and discuss best practices.

Key Purposes and Activities
Strategy Alignment: The Strategy Group (made up of the EU-LIFE board of directors, main representatives, and executive director) uses the meeting to discuss and plan for the future of research in Europe.
Best Practices Exchange: Working groups meet to share best practices in areas like core facilities, grants and funding, IT, and human resources.
Planning for the Future: The meeting allows for alignment of strategies and planning for the next year's activities.
Community Building: It fosters interaction and collaboration among all members of the EU-LIFE alliance.
Knowledge Sharing: The meeting can also include presentations and discussions on emerging topics, such as the application of artificial intelligence in life science research.
Working Groups and Task Forces: EU-LIFE has several active working groups that meet at least once a year at the community meeting to discuss specific areas of research and operations.
These working groups elect a chair who participates in strategy meetings to align activities and coordinate with other groups.

Task forces are smaller groups of experts who are brought together for specific, short-term assignments.

Abu Dhabi, United Arab Emirates

ADSCC (ABU DHABI STEM CELLS CENTER)The Abu Dhabi Stem Cells Center (ADSCC) focuses on stem cell therapy, research, and regenerative medicine, offering cutting-edge treatments and research in the UAE. It provides a comprehensive approach, encompassing basic research, clinical trials, and application of stem cell therapies. ADSCC also provides bone marrow transplant services and has been recognized as a Center of Excellence in Hematopoietic Stem Cell Transplantation.

Key activities of ADSCC include:
Stem Cell Therapy and Regenerative Medicine: ADSCC offers various treatments using stem cells, including CAR-T cell therapy, bone marrow transplants, and other cell therapies.
Research: The center conducts research on stem cells, regenerative medicine, and cell therapies, with a focus on diseases like multiple sclerosis, diabetes, and cancer.
Clinical Trials: ADSCC participates in clinical trials to evaluate the effectiveness and safety of new stem cell and cell therapy approaches.
Manufacturing and Processing: ADSCC has facilities for manufacturing and processing cell products, including CAR-T cells and other stem cell therapies, in accordance with Good Manufacturing Practice (GMP) standards.
Education and Knowledge Exchange: ADSCC is involved in educating healthcare professionals and sharing knowledge about stem cell therapy and regenerative medicine.
Partnerships: ADSCC collaborates with other healthcare institutions, universities, and research organizations to advance stem cell research and treatmen

Izola, Slovenia

InnoRenew CoEInnoRenew CoE is a Slovenian research institute focusing on renewable materials and sustainable building practices. It aims to be a world leader in this field by promoting innovation, collaboration, and public engagement. InnoRenew CoE works to advance the state of the art in nature-based solutions, particularly those using wood, to accelerate the adoption of regenerative sustainability.

Research Focus
Renewable Materials: InnoRenew CoE conducts research on various renewable materials, with a strong focus on wood and its applications.
Sustainable Building: They investigate innovative approaches to sustainable building design and construction, including the use of renewable materials and energy-efficient technologies.
Interdisciplinary Research: InnoRenew CoE employs an interdisciplinary team of scientists and professionals from various fields, such as materials science, engineering, and architecture.
Nature-Based Solutions: They explore how to incorporate nature-based solutions into the built environment to enhance sustainability and human well-being.

Key Activities
Basic and Applied Research: InnoRenew CoE conducts both basic research to expand knowledge and applied research to develop practical solutions.
Industry Collaboration: They actively collaborate with industry partners to transfer scientific knowledge into industrial practice and develop new business models.
Training and Support: InnoRenew CoE provides training and support to industry members, helping them to utilize research and development findings in their businesses.
Funding and Partnerships: They actively seek and secure funding for research projects through national and international funding programs and collaborations with other research institutes and companies.
Public Engagement: InnoRenew CoE aims to raise awareness and promote public understanding of sustainable building practices and renewable materials.

Cambridge, United Kingdom

Milner Therapeutics Symposium 2024The Milner Therapeutics Symposium is an annual event hosted by the Milner Therapeutics Institute to foster collaboration between academic and industry researchers in the field of therapeutics, particularly in areas like oncology and cancer research. It provides a platform for sharing cutting-edge research, discussing its potential applications in the pharmaceutical and biotechnology industries, and networking within the institute's partner organizations.

Purpose: The symposium aims to facilitate the translation of academic research into new therapeutic strategies and treatments.
Focus: It highlights the latest advancements in biomedical research and their potential impact on the pharmaceutical and biotechnology industries.
Format: The symposium is typically a hybrid event, featuring in-person presentations at a venue like the West Road Concert Hall in Cambridge, along with online streaming for a wider audience.
Key Activities: Keynote presentations from leading experts in academia and industry.
Scientific sessions where researchers share their latest findings.
Networking opportunities for participants to connect with potential collaborators.
Target Audience: Scientists from academia and industry, with a focus on those involved in drug discovery and development.

The symposium is organized by the Milner Therapeutics Institute, which is a research institute at the University of Cambridge that focuses on translational biomedical research, as described on its website

Cambridge, United States of America

LabCentralLabCentral in Boston serves as a shared lab and office space for biotech and life science startups. It provides entrepreneurs with a fully equipped laboratory, office space, and a supportive community to help them develop and commercialize their innovations.

What LabCentral does:
Provides lab and office space: LabCentral offers a network of fully permitted laboratory and office spaces for startups, accommodating up to 125 companies with approximately 1000 scientists and entrepreneurs.
Offers equipment and resources: They provide access to a wide range of equipment and resources, including common lab equipment for bioresearch, conference rooms, event space, and kitchens.
Supports startups: LabCentral aims to empower the next generation of biotech and life science innovators by creating opportunities for them to accelerate their development of breakthrough technology and therapies.
Fosters community and networking: They foster a community of entrepreneurs and scientists, providing access to industry and investor connections.
Offers programming and events: LabCentral hosts programming and events specific to the interests of life sciences startups, as well as training on equipment and other topics.
Provides support for diversity and inclusion: LabCentral has initiatives like LabCentral Ignite to address underrepresentation in the biotech and life sciences fields, including a program called Career Forge that assesses and places talent.
Offers Golden Tickets: Sponsors can provide promising early-stage companies with a Golden Ticket, which offers $50,000 credits towards space at LabCentral's flagship site, providing access to a full range of services, equipment, and amenities.

Boston, United States of America

Wyss Institute for Biologically Inspired EngineeringThe Wyss Institute for Biologically Inspired Engineering at Harvard University uses biological design principles to develop innovative technologies that transform medicine and create a more sustainable world. It's a research and development engine focused on creating bioinspired materials and devices, particularly in areas like healthcare, manufacturing, robotics, energy, and sustainable architecture. The Institute works to translate these discoveries into commercial products and therapies through collaborations with industry partners and startups.

Wyss Institute's mission and activities:
Key Areas of Focus:
Biologically Inspired Engineering: The Institute leverages insights from nature's construction, control, and manufacturing processes to develop new engineering innovations.
Healthcare: The Institute focuses on developing new medical technologies, including therapies, diagnostics, and devices, with the goal of improving health and well-being.
Sustainable Solutions: The Wyss Institute also works on developing sustainable solutions for various challenges, including those related to energy, manufacturing, and environmental issues.
Technology Translation: The Institute is committed to translating its discoveries into real-world applications through commercialization, collaborations, and startup formation.
Collaboration and Partnerships: The Wyss Institute operates as an alliance among Harvard's various schools and departments, including those of Medicine, Engineering, Arts & Sciences, Design, and Education.

It collaborates with leading clinical and academic institutions in the Boston area, including Beth Israel Deaconess Medical Center, Brigham and Women's Hospital, and Massachusetts Institute of Technology.

The Institute also collaborates with international partners, such as Charité – Universitätsmedizin Berlin and the University of Zurich.